Impact of recent intravenous chemotherapy on outcome in severe sepsis and septic shock patients with hematological malignancies.

Intensive Care Medicine
Dominique M VandijckJohan M Decruyenaere

Abstract

To compare the characteristics and outcome of patients with hematological malignancies referred to the ICU with severe sepsis and septic shock who had or had not received recent intravenous chemotherapy, defined as within 3 weeks prior to ICU admission. Retrospective observational cohort study on prospectively collected data in a medical ICU of a university hospital. 186 ICU patients with hematological malignancies with severe sepsis or septic shock (2000-2006). There were 77 patients admitted with severe sepsis and 109 with septic shock; 91 (49%) had received recent intravenous chemotherapy. Patients with recent chemotherapy more often had a high-grade malignancy and were more often neutropenic, less often had pulmonary infiltrates, and less often required mechanical ventilation. ICU, 28-day, in-hospital, and 6-month mortality rates were 33% vs. 48.4%, 40.7% vs. 57.4%, 45.1% vs. 58.9%, and 50.5% vs. 63.2% in patients with and without recent chemotherapy, respectively. Logistic regression identified four variables independently associated with 28-day mortality: SOFA score at ICU admission, pulmonary site of infection, and fungal infection were associated with worse outcome whereas previous intravenous chemotherapy was protectiv...Continue Reading

References

Aug 1, 1997·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·L S EltingG P Bodey
Nov 14, 1997·AJR. American Journal of Roentgenology·C P HeusselM Thelen
Feb 20, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·J S GroegerS K Kish
Dec 4, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·S AsciogluUNKNOWN Mycoses Study Group of the National Institute of Allergy and Infectious Diseases
Feb 19, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Walter T HughesLowell S Young
Mar 22, 2002·Intensive Care Medicine·Corinne AlbertiRoger Le Gall
Mar 27, 2002·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Michael A RubinBarbara C Cahill
Apr 10, 2002·Critical Care Medicine·Elie AzoulayBenoît Schlemmer
Aug 9, 2002·The New England Journal of Medicine·Raoul HerbrechtUNKNOWN Invasive Fungal Infections Group of the European Organisation for Research and Treatment of Cancer and the Global Aspergillu
Oct 24, 2002·Critical Care Medicine·Paul B MassionEtienne Installé
Jan 25, 2003·Critical Care Medicine·Jeffrey S Groeger, Peter B Bach
Apr 12, 2003·Critical Care Medicine·Mitchell M LevyUNKNOWN SCCM/ESICM/ACCP/ATS/SIS
Sep 2, 2003·International Journal of Cancer. Journal International Du Cancer·Eiichi TsujiMichio Kaminishi
Sep 19, 2003·Intensive Care Medicine·Jérôme LarchéBenoît Schlemmer
Mar 5, 2004·Intensive Care Medicine·R Phillip DellingerM M Levy
Mar 31, 2004·Intensive Care Medicine·Didier GrusonGeorges Gbikpi-Benissan
Aug 17, 2004·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Carlos J RegazzoniJuan J Poderoso
Aug 18, 2004·Critical Care : the Official Journal of the Critical Care Forum·Márcio SoaresJosé R Rocco
Nov 5, 2004·Medicine·Élie AzoulayBenoît Schlemmer
Jan 27, 2005·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Dominique D BenoitJohan M Decruyenaere
Jul 5, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Guillaume ThiéryBenoît Schlemmer
Nov 26, 2005·Intensive Care Medicine·Elie Azoulay, Bekele Afessa
Aug 22, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Márcio SoaresNelson Spector
Jan 20, 2007·Critical Care Medicine·Lucien LecuyerElie Azoulay
Jan 24, 2007·Acta Clinica Belgica·D VandijckS I Blot

❮ Previous
Next ❯

Citations

Jun 13, 2012·Medizinische Klinik, Intensivmedizin und Notfallmedizin·P Schellongowski, T Staudinger
Mar 16, 2013·Medizinische Klinik, Intensivmedizin und Notfallmedizin·T Staudinger
Feb 28, 2013·Medizinische Klinik, Intensivmedizin und Notfallmedizin·T Staudinger, P Schellongowski
Jan 25, 2008·Intensive Care Medicine·Frédéric Pène, Márcio Soares
Apr 4, 2009·Intensive Care Medicine·Dominique M VandijckJohan M Decruyenaere
Sep 22, 2009·Intensive Care Medicine·Márcio Soares, Elie Azoulay
May 19, 2010·Intensive Care Medicine·Dominique M VandijckDominique D Benoit
Mar 17, 2010·Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer·Jae-Uk SongKyeongman Jeon
Nov 3, 2010·Annals of Oncology : Official Journal of the European Society for Medical Oncology·O PenackUNKNOWN German Society of Hematology and Oncology
Feb 4, 2011·Annals of Oncology : Official Journal of the European Society for Medical Oncology·V C Souza-DantasM Soares
Oct 16, 2009·Critical Care Medicine·Márcio SoaresUNKNOWN Brazilian Research in Intensive Care Network (BRICNet)
May 14, 2009·Current Opinion in Oncology·Michael Darmon, Elie Azoulay
Sep 13, 2011·Annals of Intensive Care·Elie AzoulayBekele Afessa
Sep 14, 2014·Intensive Care Medicine·Dominique D BenoitElie Azoulay
Aug 27, 2013·Der Internist·M KochanekM von Bergwelt-Baildon
Mar 17, 2010·QJM : Monthly Journal of the Association of Physicians·S McGrathM Ostermann
Nov 26, 2013·Best Practice & Research. Clinical Anaesthesiology·Timothy James WigmoreAndrew Lawson
Oct 23, 2015·Expert Review of Anti-infective Therapy·Ligia S C F RabelloJorge If Salluh
Dec 17, 2014·Critical Care : the Official Journal of the Critical Care Forum·Matthieu SchmidtAlain Combes
Dec 1, 2009·Critical Care Clinics·Dominique D Benoit, Eric A Hoste
Dec 1, 2009·Critical Care Clinics·Márcio SoaresJorge I F Salluh
Aug 27, 2009·The Journal of Infection·Eduardo VelascoJorge I F Salluh
Feb 3, 2009·Clinics in Chest Medicine·Jason B Martin, Arthur P Wheeler
Jun 11, 2015·European Journal of Oncology Nursing : the Official Journal of European Oncology Nursing Society·Julie M FlynnNicole C Gavin
Apr 14, 2016·Memo·Peter SchellongowskiUNKNOWN Intensive Care in Hematologic-Oncologic Patients (iCHOP)
Dec 14, 2011·Acta Anaesthesiologica Scandinavica·D MokartJ-L Blache
Jan 17, 2013·Hematology·Melda TürkoğluGülsan Sucak
Aug 23, 2011·Journal of Critical Care·Maíra M RosolemMárcio Soares
May 27, 2014·Journal of Critical Care·Eirini KostakouAntonia Koutsoukou
Aug 30, 2014·The Journal of Surgical Research·Jesse D SammonQuoc-Dien Trinh

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.